ID:
1612301623282047700
Tue, 2021-02-02 18:26
LONDON: Oxford University and AstraZeneca’s COVID-19 vaccine showed in a study it had 76% efficacy against symptomatic infection for three months after a single dose, which increased if the second shot is delayed, backing Britain’s vaccine rollout policy.
The findings of the pre-print paper, which had not been peer-reviewed, supported Britain’s decision to extend the interval between initial and booster doses of the shot to 12 weeks, Oxford said on Tuesday.
Main category:
Tags:
from ArabNews https://ift.tt/3ax8WY9
via Latest News of Dubai
0 Comments